Literature DB >> 17934562

Topiramate-induced psychosis in an individual with alcohol dependence: a case report.

Kesavan Muralidharan1, Ravi Philip Rajkumar, Sreenath A Rao, Vivek Benegal.   

Abstract

Entities:  

Year:  2007        PMID： 17934562      PMCID： PMC2018845          DOI： 10.4088/pcc.v09n0411e

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  9 in total

1.  Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient.

Authors:  Alex Hofer; W Wolfgang Fleischhacker; Martina Hummer
Journal:  J Clin Psychiatry       Date:  2003-10       Impact factor: 4.384

2.  Topiramate-induced psychosis.

Authors:  Dana Kober; Glen O Gabbard
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

Review 3.  Glutamate-mediated transmission, alcohol, and alcoholism.

Authors:  P R Dodd; A M Beckmann; M S Davidson; P A Wilce
Journal:  Neurochem Int       Date:  2000 Nov-Dec       Impact factor: 3.921

4.  Topiramate blocks kainate-evoked cobalt influx into cultured neurons.

Authors:  S Skradski; H S White
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

5.  Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism.

Authors:  H S White; S D Brown; J H Woodhead; G A Skeen; H H Wolf
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

6.  Topiramate and psychiatric adverse events in patients with epilepsy.

Authors:  Marco Mula; Michael R Trimble; Samden D Lhatoo; Josemir W A S Sander
Journal:  Epilepsia       Date:  2003-05       Impact factor: 5.864

7.  Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.

Authors:  Bankole A Johnson; Nassima Ait-Daoud; Charles L Bowden; Carlo C DiClemente; John D Roache; Kevin Lawson; Martin A Javors; Jennie Z Ma
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

8.  Ethanol and negative feedback regulation of mesolimbic dopamine release in rats.

Authors:  R R Kohl; J S Katner; E Chernet; W J McBride
Journal:  Psychopharmacology (Berl)       Date:  1998-09       Impact factor: 4.530

9.  Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release.

Authors:  B Moghaddam; M L Bolinao
Journal:  Synapse       Date:  1994-12       Impact factor: 2.562
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.